PMID- 34085478
OWN - NLM
STAT- MEDLINE
DCOM- 20210607
LR  - 20210607
IS  - 0255-2930 (Print)
IS  - 0255-2930 (Linking)
VI  - 41
IP  - 6
DP  - 2021 Jun 12
TI  - [Adjuvant treatment of penetrating moxibustion at governor vessel for persistent 
      allergic rhinitis of deficiency-cold syndrome].
PG  - 623-7
LID - 10.13703/j.0255-2930.20201229-0002 [doi]
AB  - OBJECTIVE: To explore the efficacy and action mechanism of penetrating 
      moxibustion at governor vessel for persistent allergic rhinitis of 
      deficiency-cold syndrome. METHODS: Ninety patients with persistent allergic 
      rhinitis of deficiency-cold syndrome were randomly divided into an observation 
      group (n = 45) and a control group (n = 45). The patients in the control group 
      were treated with momethasone furoate nasal spray, 2 sprays per side per time, 
      once a day. On the basis of treatment in the control group, the patients in the 
      observation group were additionally treated with penetrating moxibustion at 
      governor vessel, 2 h per treatment, once a week. Both groups were treated for 4 
      weeks. The TCM symptom score, visual analogue scale (VAS) score and 
      rhinoconjunctivitis quality of life questionnaire (RQLQ) score were observed in 
      the two groups before and after treatment. The serum level of immunoglobulin E 
      (IgE) and complete blood count of eosinophil (EOS) were measured before and after 
      treatment, and the clinical effects were compared. RESULTS: Compared before 
      treatment, the TCM symptom scores, VAS scores, RQLQ scores, serum levels of IgE 
      and complete blood count of EOS in the two groups were all reduced after 
      treatment (P<0.05), and those in the observation group were lower than those in 
      the control group (P<0.05). The total effective rate in the observation group was 
      95.6% (43/45), which was higher than 82.2% (37/45) in the control group (P<0.05). 
      CONCLUSION: Based on the momethasone furoate nasal spray, the adjuvant treatment 
      of penetrating moxibustion at governor vessel could significantly improve the 
      clinical symptoms in patients with persistent allergic rhinitis of 
      deficiency-cold syndrome, and its mechanism may be related to the regulation of 
      immune disorder.
FAU - Yao, Wei-Jie
AU  - Yao WJ
AD  - Department of Otolaryngology, First Affiliated Hospital of Henan University of 
      CM, Zhengzhou 450000, China.
FAU - Liu, Pu-Zhao
AU  - Liu PZ
AD  - Department of Otolaryngology, First Affiliated Hospital of Henan University of 
      CM, Zhengzhou 450000, China.
FAU - Fan, Ya-Li
AU  - Fan YL
AD  - Department of Acupuncture and Moxibustion, Third Affiliated Hospital of Henan 
      University of CM.
FAU - Zhang, Zhi-Cheng
AU  - Zhang ZC
AD  - Department of Otolaryngology, First Affiliated Hospital of Henan University of 
      CM, Zhengzhou 450000, China.
FAU - Guo, Xiang-Dong
AU  - Guo XD
AD  - Department of Otolaryngology, First Affiliated Hospital of Henan University of 
      CM, Zhengzhou 450000, China.
FAU - Gao, Xi-Yan
AU  - Gao XY
AD  - College of Acupuncture-Moxibustion and Tuina, Henan University of CM, Zhengzhou 
      450008.
LA  - chi
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - China
TA  - Zhongguo Zhen Jiu
JT  - Zhongguo zhen jiu = Chinese acupuncture & moxibustion
JID - 8600658
SB  - IM
MH  - Acupuncture Points
MH  - Humans
MH  - *Moxibustion
MH  - Quality of Life
MH  - *Rhinitis, Allergic/drug therapy
MH  - Syndrome
MH  - Treatment Outcome
OTO - NOTNLM
OT  - deficiency-cold syndrome
OT  - penetrating moxibustion at governor vessel
OT  - persistent allergic rhinitis
OT  - randomized controlled trial (RCT)
OT  - stroke
EDAT- 2021/06/05 06:00
MHDA- 2021/06/08 06:00
CRDT- 2021/06/04 07:32
PHST- 2021/06/04 07:32 [entrez]
PHST- 2021/06/05 06:00 [pubmed]
PHST- 2021/06/08 06:00 [medline]
AID - 10.13703/j.0255-2930.20201229-0002 [doi]
PST - ppublish
SO  - Zhongguo Zhen Jiu. 2021 Jun 12;41(6):623-7. doi: 
      10.13703/j.0255-2930.20201229-0002.